
ASCO 2026 Highlights
Jul 31, 2026 - 00:33:35
Radio and PodcastLive Radio & Podcasts
Pancreatic cancer treatment has entered an exciting new chapter. On August 26, 2026, the U.S. Food and Drug Administration (FDA) approved the oral medication daraxonrasib for metastatic pancreatic cancer. This represents...